Soon Chun Hyang University   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Asan Korea, Republic of (1978)

Organization Overview

First Clinical Trial
2016
NCT03914404
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Soon Chun Hyang University

Active Ingredients

Drugs in Phase 4 Trials (2)

conjugated linoleic acid (1 trial)

thioctic acid (1 trial)

Drugs in Phase 2 Trials (2)

allogeneic stem cells (1 trial)

edoxaban (savaysa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 2)

Cerebral Infarction (Phase 2)

Diabetic Neuropathies (Phase 4)

Ischemia (Phase 2)

Pancreatitis (Phase 2)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4